Copaxone 40mg Generic: FDA Exceeds Mylan's Expectations
Executive Summary
FDA approves the product well before Mylan's prediction of 2018.
You may also be interested in...
FDA 2017 First Generics Approvals Retain India Imprint
Indian companies continued to have marked presence in list of first generics approved by US FDA in 2017; clearances include some limited competition drugs and complex products that are vital for Indian firms as they transition their portfolios away from 'plain vanilla' generics.
FDA 2017 First Generics Approvals Retain India Imprint
Indian companies continued to have marked presence in list of first generics approved by US FDA in 2017; clearances include some limited competition drugs and complex products that are vital for Indian firms as they transition their portfolios away from 'plain vanilla' generics.
US FDA Commits To Meeting With Complex ANDA Sponsors, Works Hard To Avoid It
Agency willing to talk to generic sponsors about complex product issues, but it can avoid the resource-intensive process by updating product-specific development guidances.